Log in

NASDAQ:SPNC - Spectranetics Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$38.45
0.00 (0.00 %)
(As of 08/10/2017)
Add
Today's Range
$38.45
Now: $38.45
$38.45
50-Day Range N/A
52-Week Range
$19.80
Now: $38.45
$38.55
VolumeN/A
Average Volume788,356 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. Its geographic segments are U.S. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Supplies
SectorN/A
Current SymbolNASDAQ:SPNC
CUSIP84760C10
Phone+1-719-6338333

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SPNC News and Ratings via Email

Sign-up to receive the latest news and ratings for SPNC and its competitors with MarketBeat's FREE daily newsletter.


Spectranetics (NASDAQ:SPNC) Frequently Asked Questions

What is Spectranetics' stock symbol?

Spectranetics trades on the NASDAQ under the ticker symbol "SPNC."

How were Spectranetics' earnings last quarter?

Spectranetics Corp (NASDAQ:SPNC) released its earnings results on Thursday, August, 3rd. The medical equipment provider reported ($0.56) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.27) by $0.29. The medical equipment provider earned $74.71 million during the quarter, compared to the consensus estimate of $73.82 million. The firm's quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.35) EPS. View Spectranetics' Earnings History.

Has Spectranetics been receiving favorable news coverage?

News stories about SPNC stock have been trending very negative recently, InfoTrie reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Spectranetics earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Spectranetics.

Who are some of Spectranetics' key competitors?

What other stocks do shareholders of Spectranetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spectranetics investors own include Stillwater Mining (SWC), Imax (IMAX), Integrated Device Technology (IDTI), Turquoise Hill Resources (TRQ), Skyworks Solutions (SWKS), InvenSense (INVN), Arbutus Biopharma (ABUS), Hologic (HOLX), Nektar Therapeutics (NKTR) and Intrexon (XON).

Who are Spectranetics' key executives?

Spectranetics' management team includes the folowing people:
  • B. Kristine Johnson, Chairman of the Board (Age 65)
  • Scott William Drake, President, Chief Executive Officer, Director (Age 49)
  • Stacy McMahan, Chief Financial Officer (Age 53)
  • Shahriar Matin, Chief Operating Officer (Age 42)
  • Scott Hutton, Senior Vice President and General Manager of Vascular Intervention (Age 45)
  • Donna Ford-Serbu, Senior Vice President - Sales and Marketing of Lead Management (Age 48)
  • William C. Jennings, Independent Director (Age 78)
  • Daniel A. Pelak, Independent Director (Age 65)
  • Joseph M. Ruggio M.D., Independent Director (Age 62)
  • Maria Degois Sainz, Independent Director (Age 51)

What is Spectranetics' stock price today?

One share of SPNC stock can currently be purchased for approximately $38.45.

What is Spectranetics' official website?

The official website for Spectranetics is http://www.spectranetics.com/.

How can I contact Spectranetics?

Spectranetics' mailing address is 9965 Federal Dr, COLORADO SPRINGS, CO 80921-3822, United States. The medical equipment provider can be reached via phone at +1-719-6338333.


MarketBeat Community Rating for Spectranetics (NASDAQ SPNC)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  372 (Vote Outperform)
Underperform Votes:  261 (Vote Underperform)
Total Votes:  633
MarketBeat's community ratings are surveys of what our community members think about Spectranetics and other stocks. Vote "Outperform" if you believe SPNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SPNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel